Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew S. Hayden is active.

Publication


Featured researches published by Matthew S. Hayden.


Cell | 2008

ReviewShared Principles in NF-κB Signaling

Matthew S. Hayden; Sankar Ghosh

The transcription factor NF-kappaB has served as a standard for inducible transcription factors for more than 20 years. The numerous stimuli that activate NF-kappaB, and the large number of genes regulated by NF-kappaB, ensure that this transcription factor is still the subject of intense research. Here, we attempt to synthesize some of the basic principles that have emerged from studies of NF-kappaB, and we aim to generate a more unified view of NF-kappaB regulation.


Nature Immunology | 2011

Crosstalk in NF-κB signaling pathways

Andrea Oeckinghaus; Matthew S. Hayden; Sankar Ghosh

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. A variety of stimuli coalesce on NF-κB activation, which can in turn mediate varied transcriptional programs. Consequently, NF-κB-dependent transcription is not only tightly controlled by positive and negative regulatory mechanisms but also closely coordinated with other signaling pathways. This intricate crosstalk is crucial to shaping the diverse biological functions of NF-κB into cell type– and context-specific responses.


Genes & Development | 2012

NF-κB, the first quarter-century: remarkable progress and outstanding questions

Matthew S. Hayden; Sankar Ghosh

The ability to sense and adjust to the environment is crucial to life. For multicellular organisms, the ability to respond to external changes is essential not only for survival but also for normal development and physiology. Although signaling events can directly modify cellular function, typically signaling acts to alter transcriptional responses to generate both transient and sustained changes. Rapid, but transient, changes in gene expression are mediated by inducible transcription factors such as NF-κB. For the past 25 years, NF-κB has served as a paradigm for inducible transcription factors and has provided numerous insights into how signaling events influence gene expression and physiology. Since its discovery as a regulator of expression of the κ light chain gene in B cells, research on NF-κB continues to yield new insights into fundamental cellular processes. Advances in understanding the mechanisms that regulate NF-κB have been accompanied by progress in elucidating the biological significance of this transcription factor in various physiological processes. NF-κB likely plays the most prominent role in the development and function of the immune system and, not surprisingly, when dysregulated, contributes to the pathophysiology of inflammatory disease. As our appreciation of the fundamental role of inflammation in disease pathogenesis has increased, so too has the importance of NF-κB as a key regulatory molecule gained progressively greater significance. However, despite the tremendous progress that has been made in understanding the regulation of NF-κB, there is much that remains to be understood. In this review, we highlight both the progress that has been made and the fundamental questions that remain unanswered after 25 years of study.


Cell Metabolism | 2011

NF-κB, inflammation and metabolic disease

Rebecca G. Baker; Matthew S. Hayden; Sankar Ghosh

Metabolic disorders including obesity, type 2 diabetes, and atherosclerosis have been viewed historically as lipid storage disorders brought about by overnutrition. It is now widely appreciated that chronic low-grade inflammation plays a key role in the initiation, propagation, and development of metabolic diseases. Consistent with its central role in coordinating inflammatory responses, numerous recent studies have implicated the transcription factor NF-κB in the development of such diseases, thereby further establishing inflammation as a critical factor in their etiology and offering hope for the development of new therapeutic approaches for their treatment.


Cell Research | 2011

NF-κB in immunobiology

Matthew S. Hayden; Sankar Ghosh

NF-κB was first discovered and characterized 25 years ago as a key regulator of inducible gene expression in the immune system. Thus, it is not surprising that the clearest biological role of NF-κB is in the development and function of the immune system. Both innate and adaptive immune responses as well as the development and maintenance of the cells and tissues that comprise the immune system are, at multiple steps, under the control of the NF-κB family of transcription factors. Although this is a well-studied area of NF-κB research, new and significant findings continue to accumulate. This review will focus on these areas of recent progress while also providing a broad overview of the roles of NF-κB in mammalian immunobiology.


Seminars in Immunology | 2014

Regulation of NF-κB by TNF Family Cytokines

Matthew S. Hayden; Sankar Ghosh

The NF-κB family of inducible transcription factors is activated in response to a variety of stimuli. Amongst the best-characterized inducers of NF-κB are members of the TNF family of cytokines. Research on NF-κB and TNF have been tightly intertwined for more than 25 years. Perhaps the most compelling examples of the interconnectedness of NF-κB and the TNF have come from analysis of knock-out mice that are unable to activate NF-κB. Such mice die embryonically, however, deletion of TNF or TNFR1 can rescue the lethality thereby illustrating the important role of NF-κB as the key regulator of transcriptional responses to TNF. The physiological connections between NF-κB and TNF cytokines are numerous and best explored in articles focusing on a single TNF family member. Instead, in this review, we explore general mechanisms of TNF cytokine signaling, with a focus on the upstream signaling events leading to activation of the so-called canonical and noncanonical NF-κB pathways by TNFR1 and CD40, respectively.


Immunological Reviews | 2012

Celebrating 25 years of NF-κB research

Sankar Ghosh; Matthew S. Hayden

In the 25 years since its discovery, the nuclear factor-κB (NF-κB) family of transcription factors has been the subject of intensive research in virtually all areas of biomedical science. Research into the function and regulation of this single transcription factor family has been at the forefront of studies in immunology, cancer biology, and molecular pathology, and has progressed hand in hand with conceptual and technological advances in molecular biology, genetic engineering, systems biology, and computational biology. The progress made in elucidating the triggers of NF-κB activation, the components of the NF-κB pathway, and characterization of the physiological and pathophysiological functions of NF-κB have been remarkable. This anniversary therefore represents an excellent opportunity to revisit the work that forms the foundation upon which so much effort and progress has been built. The articles in this volume of Immunological Reviews cover much of what is known about the NF-κB pathway and its basic function. Yet each review also draws attention to the myriad and often surprisingly fundamental issues that remain unresolved. Finally, in marking this important landmark, most reviewers have shared a personal and historical narrative documenting their connection to their area of study in NF-κB. These accounts offer a unique view of the early days of NF-κB research, when so much of the fundamental underpinnings of the pathway were laid down in short order, and provide particular insight into how this field was enriched through the expertise of scientific immigrants from disparate areas of biology, further highlighting the amazing diversity of biological systems influenced by this single transcription factor family. In this introductory article, we lay down some of the most basic and fundamental concepts in order to assist the uninitiated in gaining access to the more detailed discussions that characterize the rest of this issue. Thus, this represents a severely abridged introduction to the NF-κB signaling pathway and its biological function. Where appropriate, we point the reader towards reviews elsewhere in this issue from which they may gain more detailed insight and historical context to the various facets of NF-κB. However, in keeping with the format of this issue, I (S.G.) begin by offering an account of my own involvement with NF-κB.


Journal of Cell Biology | 2006

CHMP5 is essential for late endosome function and down-regulation of receptor signaling during mouse embryogenesis

Jae-Hyuck Shim; Changchun Xiao; Matthew S. Hayden; Ki-Young Lee; E. Sergio Trombetta; Marc Pypaert; Atsuki Nara; Tamotsu Yoshimori; Bettina Wilm; Hediye Erdjument-Bromage; Paul Tempst; Brigid L.M. Hogan; Ira Mellman; Sankar Ghosh

Charged MVB protein 5 (CHMP5) is a coiled coil protein homologous to the yeast Vps60/Mos10 gene and other ESCRT-III complex members, although its precise function in either yeast or mammalian cells is unknown. We deleted the CHMP5 gene in mice, resulting in a phenotype of early embryonic lethality, reflecting defective late endosome function and dysregulation of signal transduction. Chmp5 −/− cells exhibit enlarged late endosomal compartments that contain abundant internal vesicles expressing proteins that are characteristic of late endosomes and lysosomes. This is in contrast to ESCRT-III mutants in yeast, which are defective in multivesicular body (MVB) formation. The degradative capacity of Chmp5 −/− cells was reduced, and undigested proteins from multiple pathways accumulated in enlarged MVBs that failed to traffic their cargo to lysosomes. Therefore, CHMP5 regulates late endosome function downstream of MVB formation, and the loss of CHMP5 enhances signal transduction by inhibiting lysosomal degradation of activated receptors.


Nature | 2010

IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.

Ping Rao; Matthew S. Hayden; Meixiao Long; Martin L. Scott; A P West; Dekai Zhang; Andrea Oeckinghaus; Candace Lynch; Alexander Hoffmann; David Baltimore; Sankar Ghosh

The activation of pro-inflammatory gene programs by nuclear factor-κB (NF-κB) is primarily regulated through cytoplasmic sequestration of NF-κB by the inhibitor of κB (IκB) family of proteins. IκBβ, a major isoform of IκB, can sequester NF-κB in the cytoplasm, although its biological role remains unclear. Although cells lacking IκBβ have been reported, in vivo studies have been limited and suggested redundancy between IκBα and IκBβ. Like IκBα, IκBβ is also inducibly degraded; however, upon stimulation by lipopolysaccharide (LPS), it is degraded slowly and re-synthesized as a hypophosphorylated form that can be detected in the nucleus. The crystal structure of IκBβ bound to p65 suggested this complex might bind DNA. In vitro, hypophosphorylated IκBβ can bind DNA with p65 and c-Rel, and the DNA-bound NF-κB:IκBβ complexes are resistant to IκBα, suggesting hypophosphorylated, nuclear IκBβ may prolong the expression of certain genes. Here we report that in vivo IκBβ serves both to inhibit and facilitate the inflammatory response. IκBβ degradation releases NF-κB dimers which upregulate pro-inflammatory target genes such as tumour necrosis factor-α (TNF-α). Surprisingly, absence of IκBβ results in a dramatic reduction of TNF-α in response to LPS even though activation of NF-κB is normal. The inhibition of TNF-α messenger RNA (mRNA) expression correlates with the absence of nuclear, hypophosphorylated-IκBβ bound to p65:c-Rel heterodimers at a specific κB site on the TNF-α promoter. Therefore IκBβ acts through p65:c-Rel dimers to maintain prolonged expression of TNF-α. As a result, IκBβ−/− mice are resistant to LPS-induced septic shock and collagen-induced arthritis. Blocking IκBβ might be a promising new strategy for selectively inhibiting the chronic phase of TNF-α production during the inflammatory response.


PLOS ONE | 2013

A Role for NF-κB Activity in Skin Hyperplasia and the Development of Keratoacanthomata in Mice

Brian Poligone; Matthew S. Hayden; Luojing Chen; Alice P. Pentland; Eijiro Jimi; Sankar Ghosh

Background Previous studies have implicated NF-κB signaling in both cutaneous development and oncogenesis. However, these studies have been limited in part by the lethality that results from extreme over- or under-expression of NF-κB in available mouse models. Even cre-driven tissue specific expression of transgenes, or targeted deletion of NF-κB can cause cell death. Therefore, the present study was undertaken to evaluate a novel mouse model of enhanced NF-κB activity in the skin. Methods A knock-in homologous recombination technique was utilized to develop a mouse model (referred to as PD mice) with increased NF-κB activity. Results The data show that increased NF-κB activity leads to hyperproliferation and dysplasia of the mouse epidermis. Chemical carcinogenesis in the context of enhanced NF-κB activity promotes the development of keratoacanthomata. Conclusion Our findings support an important role for NF-κB in keratinocyte dysplasia. We have found that enhanced NF-κB activity renders keratinocytes susceptible to hyperproliferation and keratoacanthoma (KA) development but is not sufficient for transformation and SCC development. We therefore propose that NF-κB activation in the absence of additional oncogenic events can promote TNF-dependent, actinic keratosis-like dysplasia and TNF-independent, KAs upon chemical carcinogensis. These studies suggest that resolution of KA cannot occur when NF-κB activation is constitutively enforced.

Collaboration


Dive into the Matthew S. Hayden's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sung-Gyoo Park

Gwangju Institute of Science and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge